![Maria Alba](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Maria Alba worked as Global Medical Leader at Amicus Therapeutics, Inc. Dr. Alba worked as Vice President-Clinical Research at Immunovant, Inc. from 2022 to 2026.
Dr. Alba earned a doctorate from The Catholic University of America.
Former positions of Maria Alba
| Companies | Position | End |
|---|---|---|
| IMMUNOVANT, INC. | Chief Tech/Sci/R&D Officer | 2026-03-30 |
| AMICUS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Training of Maria Alba
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
6
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
The Catholic University of America
 The Catholic University of America Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Maria Alba
